E

Researcher Profile

Eric Sung

🏛 eFFECTOR Therapeutics, San Diego, CA.

1

Publications

5

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article Cancer Research Jul 01, 2019

Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma

Peggy A. Thompson · Boreth Eam · Nathan P. Young · Sarah Fish +20 more

10.1158/1538-7445.am2019-2698 5 citations

Publication Timeline

2019

1

Frequent Co-Authors

Garrick K. Packard

Jocelyn Staunton

Christian Nilewski

Justin T. Ernst

Paul A. Sprengeler